Study on platelet components production in 19 provincial blood centers in China before and during the COVID-19 epidemic
- VernacularTitle:新冠疫情前后我国19家省级血液中心血小板成分血生产量研究
- Author:
Yuan ZHANG
1
;
Yang CHEN
2
;
Lin WANG
3
;
Zhian ZHANG
4
;
Ying LI
5
;
Jincai ZHANG
6
;
Mengzhuo LUO
7
;
Huiling MENG
8
;
Juan ZHOU
9
;
Xia DU
10
;
Changchun LU
11
;
Ying XIE
12
;
Li DENG
13
;
Huijuan AN
14
;
Sheling LIANG
15
;
Yang ZHANG
16
;
Yan LAN
17
;
Yuan ZHOU
18
;
Yan QIU
19
Author Information
- Publication Type:Journal Article
- Keywords: COVID-19; platelet components; apheresis platelet; pooled platelet concentrates; production
- From: Chinese Journal of Blood Transfusion 2023;36(10):898-902
- CountryChina
- Language:Chinese
- Abstract: 【Objective】 To study the changes of platelet components(PC), apheresis platelets (AP) and pooled platelet concentrates (PPC) production of 19 provincial blood centers before and during the COVID-19 epidemic. 【Methods】 The data related to the collection of AP and the preparation of PPC from 2016 to 2021 of 19 provincial blood centers was collected. The production of PC, AP and PPC during the four years before the epidemic (i.e. 2016-2019) and during the COVID-19 epidemic (i.e. 2020 and 2021) were calculated respectively, and the change of production was analyzed. 【Results】 The total production of PC in 19 blood centers steadily increased from 2016 to 2019, with a decrease of 4.16% in 2020 and an increase of 15.60% in 2021, exceeding the output before the COVID-19 epidemic. In 2020, the production of PC of 42.11% (8/19) blood centers decreased compared with 2019, while 94.74% (18/19) in 2021 increased compared with 2020. The changes of AP output was basically consistent with the trend of PC. The total production of PPC in 2017 and 2018 both doubled compared to the previous year, while decreased by 67.98% in 2019, increased by 30.38% in 2020 and decreased by 27.08% in 2021. 【Conclusion】 The total production of PC kept increasing steadily between 2016 and 2019, but decreased in 2020 under the COVID-19 epidemic, with some blood centers being significantly affected. In 2021, with the strong support from government and various measures by blood centers, the total production of PC increased.